OTCMKTS:SDMHF - Sartorius Stedim Biotech Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$337.90
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Sartorius Stedim Biotech Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SDMHF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SDMHF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Sartorius Stedim Biotech in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $337.90.
Hold
The current consensus among 5 polled investment analysts is to hold stock in Sartorius Stedim Biotech. This rating has held steady since May 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetDetails
10/23/2020Berenberg BankReiterated RatingBuy
i
10/22/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
10/22/2020Societe GeneraleUpgradeHold ➝ Buy
i
9/25/2020Berenberg BankInitiated CoverageBuy
i
8/6/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
6/11/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
6/8/2020UBS GroupDowngradeNeutral ➝ Sell
i
1/31/2020UBS GroupDowngradeBuy ➝ Neutral
i
(Data available from 11/28/2015 forward)
Sartorius Stedim Biotech logo
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, fluid management services, and membrane chromatography services. In addition, the company offers data analytics software for modeling and optimizing processed of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Read More

Today's Range

Now: $337.90
$337.90
$337.90

50 Day Range

MA: $370.75
$337.90
$422.75

52 Week Range

Now: $337.90
$144.79
$422.75

Volume

N/A

Average Volume

252 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A